Fort Walton Beach Medical Center | |
1000 Mar-walt Dr, Fort Walton Beach, Florida 32547 | |
(850) 862-1111 | |
Name | Fort Walton Beach Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 1000 Mar-walt Dr, Fort Walton Beach, Florida |
Ownership | Proprietary |
Emergency Services | Yes |
Medicare ID (CCN) | 100223 |
NPI Number | 1104875699 |
Organization Name | FORT WALTON BEACH MEDICAL CENTER, INC. |
Doing Business As | FORT WALTON BEACH MEDICAL CENTER |
Address | 1000 Mar Walt Dr, Ft Walton Beach, FL 32547 |
Hospital Type | General Acute Care Hospital |
Phone Number | 850-862-1111 |
News Archive
Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka's Board of Directors.
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
According to news outlets, the report focused on the care of patients with disabilities, and steps to make sure anti-fraud efforts don't add to states' burdens.
Carbonated soft drink consumption was previously suggested to be linked to the 350 percent increase of adenocarcinoma of the esophagus since the mid-1970s, but researchers at Yale School of Medicine report that the link is unfounded and that there may, in fact, be a decreased risk of this cancer for diet soda drinkers.
› Verified 2 days ago
NPI Number | 1518973908 |
Organization Name | 96TH MDG EGLIN AFB |
Address | 1000 Mar Walt Dr, Fort Walton Beach, FL 32547 |
Hospital Type | Military Hospital |
Phone Number | 850-862-1111 |
News Archive
Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka's Board of Directors.
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
According to news outlets, the report focused on the care of patients with disabilities, and steps to make sure anti-fraud efforts don't add to states' burdens.
Carbonated soft drink consumption was previously suggested to be linked to the 350 percent increase of adenocarcinoma of the esophagus since the mid-1970s, but researchers at Yale School of Medicine report that the link is unfounded and that there may, in fact, be a decreased risk of this cancer for diet soda drinkers.
› Verified 2 days ago
NPI Number | 1639128820 |
Organization Name | FORT WALTON BEACH MEDICAL CENTER, INC. |
Doing Business As | HCA FLORIDA FORT WALTON-DESTIN HOSPITAL |
Address | 1000 Mar Walt Dr, Ft Walton Beach, FL 32547 |
Hospital Type | General Acute Care Hospital |
Phone Number | 850-862-1111 |
News Archive
Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka's Board of Directors.
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
According to news outlets, the report focused on the care of patients with disabilities, and steps to make sure anti-fraud efforts don't add to states' burdens.
Carbonated soft drink consumption was previously suggested to be linked to the 350 percent increase of adenocarcinoma of the esophagus since the mid-1970s, but researchers at Yale School of Medicine report that the link is unfounded and that there may, in fact, be a decreased risk of this cancer for diet soda drinkers.
› Verified 2 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka's Board of Directors.
A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.
According to news outlets, the report focused on the care of patients with disabilities, and steps to make sure anti-fraud efforts don't add to states' burdens.
Carbonated soft drink consumption was previously suggested to be linked to the 350 percent increase of adenocarcinoma of the esophagus since the mid-1970s, but researchers at Yale School of Medicine report that the link is unfounded and that there may, in fact, be a decreased risk of this cancer for diet soda drinkers.
› Verified 2 days ago
Fort Walton Beach Medical Center Acute Care Hospital Location: 1000 Mar-walt Dr, Fort Walton Beach, Florida 32547 Phone: (850) 862-1111 |